US Stock MarketDetailed Quotes

SMMT Summit Therapeutics

Watchlist
  • 4.320
  • -0.070-1.59%
Close May 23 16:00 ET
  • 4.440
  • +0.120+2.78%
Post 18:50 ET
3.03BMarket Cap11.37P/E (TTM)

Summit Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-129.49%-30.13M
-84.60%-76.76M
-474.86%-19.46M
-74.13%-14.9M
-52.33%-29.27M
30.89%-13.13M
42.71%-41.58M
156.55%5.19M
63.70%-8.56M
-0.22%-19.22M
Net income from continuing operations
91.98%-43.47M
-680.54%-614.93M
-90.17%-36.57M
0.55%-21.27M
12.25%-14.72M
-2,434.82%-542.38M
11.08%-78.78M
29.04%-19.23M
-9.11%-21.39M
31.31%-16.77M
Operating gains losses
101.01%9K
-151.22%-1.34M
73.41%-440K
-73.49%505K
-138.83%-516K
-185.73%-889K
702.45%2.62M
-270.62%-1.66M
123.85%1.91M
493.30%1.33M
Depreciation and amortization
-70.00%27K
-18.46%2.05M
1.51%605K
-15.87%599K
27.92%756K
-85.37%90K
2.40%2.51M
-11.18%596K
12.66%712K
-11.13%591K
Other non cash items
----
17,252.47%527.17M
-96.25%82K
28.41%-63K
-76.99%171K
266,050.51%526.98M
511.27%3.04M
12,752.94%2.19M
-153.33%-88K
250.47%743K
Change In working capital
2,393.99%4.2M
-127.48%-2.37M
-31.66%8.32M
-54.15%3.44M
-83.31%-13.94M
94.70%-183K
12,959.70%8.62M
14.34%12.17M
190.86%7.5M
-1,721.54%-7.61M
-Change in receivables
-47.33%632K
-51.90%4.53M
-101.66%-178K
15,790.91%3.45M
196.36%53K
199.09%1.2M
231.58%9.41M
64.01%10.7M
99.57%-22K
98.85%-55K
-Change in prepaid assets
-943.50%-2.79M
-117.90%-914K
2,513.86%2.64M
-73.22%1.01M
-237.42%-4.9M
-87.66%331K
117.78%5.11M
-92.11%101K
230.04%3.78M
-162.27%-1.45M
-Change in payables and accrued expense
198.00%2.16M
-115.45%-349K
301.28%6.59M
-61.46%2.12M
-108.58%-6.86M
-37.84%-2.2M
-65.34%2.26M
-33.09%1.64M
1,727.51%5.5M
-172.70%-3.29M
-Change in other current assets
398.23%2.53M
-1,691.16%-3.42M
87.46%-43K
-224.75%-2.46M
-37.60%-1.43M
237.30%508K
106.73%215K
-284.41%-343K
810.47%1.97M
-193.79%-1.04M
-Change in other current liabilities
--1.76M
-101.18%-2.21M
-232.69%-692K
-131.65%-688K
-179.80%-831K
--0
-2.90%-1.1M
36.00%-208K
-1.71%-297K
0.67%-297K
-Change in other working capital
-318.18%-92K
----
----
----
----
99.17%-22K
-795.20%-7.28M
-47.23%276K
-609.99%-3.42M
-55.49%-1.47M
Cash from discontinued investing activities
Operating cash flow
-129.49%-30.13M
-84.60%-76.76M
-474.86%-19.46M
-74.13%-14.9M
-52.33%-29.27M
30.89%-13.13M
42.71%-41.58M
156.55%5.19M
63.70%-8.56M
-0.22%-19.22M
Investing cash flow
Cash flow from continuing investing activities
103.08%19.87M
-94,094.55%-587.77M
605,580.00%60.57M
-17,530.00%-3.49M
170.65%207K
-178,587.81%-645.06M
-103.92%-624K
108.33%10K
400.00%20K
-94.04%-293K
Net PPE purchase and sale
92.45%-4K
115.71%98K
-120.00%-2K
-365.00%-53K
170.31%206K
85.32%-53K
-103.92%-624K
108.33%10K
400.00%20K
-94.04%-293K
Net investment purchase and sale
111.69%19.88M
---112.86M
--60.57M
---3.43M
--1K
---170M
--0
--0
--0
--0
Net other investing changes
----
---475.02M
--0
--0
--0
---475.02M
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
103.08%19.87M
-94,094.55%-587.77M
605,580.00%60.57M
-17,530.00%-3.49M
170.65%207K
-178,587.81%-645.06M
-103.92%-624K
108.33%10K
400.00%20K
-94.04%-293K
Financing cash flow
Cash flow from continuing financing activities
-99.39%485K
-86.05%86.51M
-98.80%6.25M
-99.69%229K
-80K
218.07%80.11M
696.04%620.24M
41,141.87%520.06M
10,994.23%75M
0
Net issuance payments of debt
--0
-104.75%-24.69M
--0
--0
--0
-198.74%-24.69M
--520M
--520M
---25M
--0
Net common stock issuance
----
--5M
----
----
----
----
--0
----
----
----
Proceeds from stock option exercised by employees
-99.54%485K
6.39%106.82M
1,103.85%1.25M
-99.77%229K
--0
56,229.95%105.34M
3,151.26%100.4M
100.14%104K
13,613.42%100.11M
--0
Net other financing activities
----
-299.35%-619K
--0
--0
---80K
---539K
9.88%-155K
-207.32%-44K
----
----
Cash from discontinued financing activities
Financing cash flow
-99.39%485K
-86.05%86.51M
-98.80%6.25M
-99.69%229K
---80K
218.07%80.11M
696.04%620.24M
41,141.87%520.06M
10,994.23%75M
--0
Net cash flow
Beginning cash position
-88.99%71.43M
803.47%648.61M
-80.49%23.79M
-26.54%42.12M
-8.37%70.97M
803.47%648.61M
8.09%71.79M
51.99%121.97M
-44.54%57.34M
-24.21%77.45M
Current changes in cash
98.31%-9.78M
-200.00%-578.02M
-90.98%47.36M
-127.31%-18.15M
-49.39%-29.15M
-10,024.15%-578.08M
11,407.82%578.04M
6,634.72%525.26M
390.42%66.46M
-2,677.28%-19.51M
Effect of exchange rate changes
-108.11%-36K
168.66%839K
-80.22%272K
90.69%-170K
148.43%293K
367.47%444K
-448.15%-1.22M
428.16%1.38M
-621.74%-1.83M
-239.08%-605K
End cash Position
-13.19%61.61M
-88.99%71.43M
-88.99%71.43M
-80.49%23.79M
-26.54%42.12M
-8.37%70.97M
803.47%648.61M
803.47%648.61M
51.99%121.97M
-44.54%57.34M
Free cash flow
-128.60%-30.14M
-82.17%-76.89M
-474.18%-19.46M
-75.16%-14.95M
-50.14%-29.29M
31.91%-13.18M
42.10%-42.21M
155.93%5.2M
63.77%-8.54M
-0.96%-19.51M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -129.49%-30.13M-84.60%-76.76M-474.86%-19.46M-74.13%-14.9M-52.33%-29.27M30.89%-13.13M42.71%-41.58M156.55%5.19M63.70%-8.56M-0.22%-19.22M
Net income from continuing operations 91.98%-43.47M-680.54%-614.93M-90.17%-36.57M0.55%-21.27M12.25%-14.72M-2,434.82%-542.38M11.08%-78.78M29.04%-19.23M-9.11%-21.39M31.31%-16.77M
Operating gains losses 101.01%9K-151.22%-1.34M73.41%-440K-73.49%505K-138.83%-516K-185.73%-889K702.45%2.62M-270.62%-1.66M123.85%1.91M493.30%1.33M
Depreciation and amortization -70.00%27K-18.46%2.05M1.51%605K-15.87%599K27.92%756K-85.37%90K2.40%2.51M-11.18%596K12.66%712K-11.13%591K
Other non cash items ----17,252.47%527.17M-96.25%82K28.41%-63K-76.99%171K266,050.51%526.98M511.27%3.04M12,752.94%2.19M-153.33%-88K250.47%743K
Change In working capital 2,393.99%4.2M-127.48%-2.37M-31.66%8.32M-54.15%3.44M-83.31%-13.94M94.70%-183K12,959.70%8.62M14.34%12.17M190.86%7.5M-1,721.54%-7.61M
-Change in receivables -47.33%632K-51.90%4.53M-101.66%-178K15,790.91%3.45M196.36%53K199.09%1.2M231.58%9.41M64.01%10.7M99.57%-22K98.85%-55K
-Change in prepaid assets -943.50%-2.79M-117.90%-914K2,513.86%2.64M-73.22%1.01M-237.42%-4.9M-87.66%331K117.78%5.11M-92.11%101K230.04%3.78M-162.27%-1.45M
-Change in payables and accrued expense 198.00%2.16M-115.45%-349K301.28%6.59M-61.46%2.12M-108.58%-6.86M-37.84%-2.2M-65.34%2.26M-33.09%1.64M1,727.51%5.5M-172.70%-3.29M
-Change in other current assets 398.23%2.53M-1,691.16%-3.42M87.46%-43K-224.75%-2.46M-37.60%-1.43M237.30%508K106.73%215K-284.41%-343K810.47%1.97M-193.79%-1.04M
-Change in other current liabilities --1.76M-101.18%-2.21M-232.69%-692K-131.65%-688K-179.80%-831K--0-2.90%-1.1M36.00%-208K-1.71%-297K0.67%-297K
-Change in other working capital -318.18%-92K----------------99.17%-22K-795.20%-7.28M-47.23%276K-609.99%-3.42M-55.49%-1.47M
Cash from discontinued investing activities
Operating cash flow -129.49%-30.13M-84.60%-76.76M-474.86%-19.46M-74.13%-14.9M-52.33%-29.27M30.89%-13.13M42.71%-41.58M156.55%5.19M63.70%-8.56M-0.22%-19.22M
Investing cash flow
Cash flow from continuing investing activities 103.08%19.87M-94,094.55%-587.77M605,580.00%60.57M-17,530.00%-3.49M170.65%207K-178,587.81%-645.06M-103.92%-624K108.33%10K400.00%20K-94.04%-293K
Net PPE purchase and sale 92.45%-4K115.71%98K-120.00%-2K-365.00%-53K170.31%206K85.32%-53K-103.92%-624K108.33%10K400.00%20K-94.04%-293K
Net investment purchase and sale 111.69%19.88M---112.86M--60.57M---3.43M--1K---170M--0--0--0--0
Net other investing changes -------475.02M--0--0--0---475.02M----------------
Cash from discontinued investing activities
Investing cash flow 103.08%19.87M-94,094.55%-587.77M605,580.00%60.57M-17,530.00%-3.49M170.65%207K-178,587.81%-645.06M-103.92%-624K108.33%10K400.00%20K-94.04%-293K
Financing cash flow
Cash flow from continuing financing activities -99.39%485K-86.05%86.51M-98.80%6.25M-99.69%229K-80K218.07%80.11M696.04%620.24M41,141.87%520.06M10,994.23%75M0
Net issuance payments of debt --0-104.75%-24.69M--0--0--0-198.74%-24.69M--520M--520M---25M--0
Net common stock issuance ------5M------------------0------------
Proceeds from stock option exercised by employees -99.54%485K6.39%106.82M1,103.85%1.25M-99.77%229K--056,229.95%105.34M3,151.26%100.4M100.14%104K13,613.42%100.11M--0
Net other financing activities -----299.35%-619K--0--0---80K---539K9.88%-155K-207.32%-44K--------
Cash from discontinued financing activities
Financing cash flow -99.39%485K-86.05%86.51M-98.80%6.25M-99.69%229K---80K218.07%80.11M696.04%620.24M41,141.87%520.06M10,994.23%75M--0
Net cash flow
Beginning cash position -88.99%71.43M803.47%648.61M-80.49%23.79M-26.54%42.12M-8.37%70.97M803.47%648.61M8.09%71.79M51.99%121.97M-44.54%57.34M-24.21%77.45M
Current changes in cash 98.31%-9.78M-200.00%-578.02M-90.98%47.36M-127.31%-18.15M-49.39%-29.15M-10,024.15%-578.08M11,407.82%578.04M6,634.72%525.26M390.42%66.46M-2,677.28%-19.51M
Effect of exchange rate changes -108.11%-36K168.66%839K-80.22%272K90.69%-170K148.43%293K367.47%444K-448.15%-1.22M428.16%1.38M-621.74%-1.83M-239.08%-605K
End cash Position -13.19%61.61M-88.99%71.43M-88.99%71.43M-80.49%23.79M-26.54%42.12M-8.37%70.97M803.47%648.61M803.47%648.61M51.99%121.97M-44.54%57.34M
Free cash flow -128.60%-30.14M-82.17%-76.89M-474.18%-19.46M-75.16%-14.95M-50.14%-29.29M31.91%-13.18M42.10%-42.21M155.93%5.2M63.77%-8.54M-0.96%-19.51M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg